Live from the NIH registry
Studies recruiting near Thousand Oaks right now
Top 25 of 684 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Woodland Hills — Woodland Hills, California (15.5 mi)
· Sponsor: SWOG Cancer Research Network
Housing Transitions QUERI
Homelessness
Phase 1
Interventional 153 participants sought
VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California (27.4 mi)
· Sponsor: VA Office of Research and Development
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Sylmar, California (25.6 mi)
· Sponsor: AstraZeneca
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
California Retina Consultants-Oxnard-70187 — Oxnard, California (17.2 mi)
· Sponsor: Boehringer Ingelheim
Phase 1 Study of C.001 in Retinal Degeneration
Geographic Atrophy, Stargardt Disease
Phase 1
Interventional 15 participants sought
Retina Vision Consultants — Beverly Hills, California (28.4 mi)
· Sponsor: Cellio Therapeutics Inc
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Center for Rheumatology Research — Woodland Hills, California (15.5 mi)
· Sponsor: University of Alabama at Birmingham
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10109, Van Nuys, CA — Van Nuys, California (24.4 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 3
Interventional 641 participants sought
Genesis Research LLC 1 — Sherman Oaks, California (24.5 mi)
· Sponsor: Janssen Research & Development, LLC
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Beverly Hills, California (28.4 mi)
· Sponsor: AstraZeneca
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Woodland Hills — Woodland Hills, California (15.5 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Interventional Cardiology Medical Group — West Hills, California (13.2 mi)
· Sponsor: Duke University
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (25.0 mi)
· Sponsor: Astellas Pharma Inc
A Study of ASP3082 in Adults With Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 681 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (25.0 mi)
· Sponsor: Astellas Pharma Inc
Aveir DR Real-World Evidence Post-Approval Study
Cardiac Pacemaker, Arrythmia
N/A
Observational 1,805 participants sought
Abbott — Sylmar, California (25.6 mi)
· Sponsor: Abbott Medical Devices
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
Precision NextGen Oncology & Research Center — Beverly Hills, California (28.4 mi)
· Sponsor: Context Therapeutics Inc.
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
Angiokeratomas
Phase 2
Interventional 15 participants sought
Unified Health — Sherman Oaks, California (24.5 mi)
· Sponsor: Palvella Therapeutics, Inc.
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Prediabetic State, Atherosclerosis
Phase 4
Interventional 7,410 participants sought
VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California (27.4 mi)
· Sponsor: VA Office of Research and Development
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Providence Saint John's Health Center ( Site 0059) — Santa Monica, California (25.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Millennium Clinical Trials — Westlake Village, California (5.1 mi)
· Sponsor: Novartis Pharmaceuticals
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Metastatic Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 51 participants sought
Olive View-University of California Los Angeles Medical Center — Sylmar, California (25.6 mi)
· Sponsor: University of Washington
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
UCLA Hematology/Oncology - Westlake — Westlake Village, California (5.1 mi)
· Sponsor: Pfizer
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (2.6 mi)
· Sponsor: Incyte Corporation
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Lung Neoplasm
N/A
Interventional 670 participants sought
VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California (27.4 mi)
· Sponsor: VA Office of Research and Development
Endotypic Traits and Obstructive Sleep Apnea Surgery
Obstructive Sleep Apnea
Phase 2
Interventional 150 participants sought
UCLA Santa Monica Medical Center — Santa Monica, California (25.0 mi)
· Sponsor: University of California, Los Angeles
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
San Fernando Valley Health Institute /ID# 257363 — West Hills, California (13.2 mi)
· Sponsor: AbbVie